ArticleScientific reports2018

Bufalin suppresses hepatocarcinogenesis by targeting β-catenin/TCF signaling via cell cycle-related kinase.

Zhuo Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.